Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial 3. Februar 2022 24. September 2020 Share EmailTwitterFacebookGoogle +PinterestTumblrLinkedinVkontakte